Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Primary palmar hyperhidrosis is a distressing and disabling condition that can produce social, psychological and occupational problems. Although the use of botulinum toxin type A (BoNT-A) has been reported as an efficacious and safe intervention to improve palmar hyperhidrosis, only one study concerned botulinum toxin type B (BoNT-B) in this disorder. The aim of study was to evaluate the efficacy and safety of BoNT-B in treating primary palmar hyperhidrosis. Participants were injected with 5,000 IU of BoNT-B in each palm. Visual analogue test (VAS) to evaluate the intensity of decrease in sweat production, Minor’s iodine starch test and measurement of paper towels’ weight were used to ascertain palmar sweating at baseline, 4, 12 and 24 weeks after BoNT-B injections by a blind examiner. Thirty-two subjects (12 males, 20 females, mean age 31 ± 11) were enrolled. Significant reduction of palmar sweating was detected after BoNT-B injection: 2.9 ± 1.4, 0.3 ± 0.4, 0.9 ± 0.8, and 2.1 ± 1.5 g (p < 0.001) of paper towels’ weight for the right palm at baseline, 4, 12 and 24 weeks; and 2.8 ± 1.7, 0.5 ± 0.6, 0.8 ± 0.7, and 1.8 ± 1.25 g (p < 0.001) at same time, respectively for the left palm. Significant reduction of mean VAS values were also detected after BoNT-B injections: 8.6 ± 1.1, 0.6 ± 0.8, 3.5 ± 2.5, and 7.1 ± 2.4 (p < 0.0001) at baseline, 4, 12 and 24 weeks, respectively. Mild side effects consisting in local pain and hand weakness were observed in 4 (12.5 %) subjects. The findings indicated that the use of 5,000 IU BoNT-B injection in each palm was safe and significantly improved the severity of palmar hyperhidrosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Atkinson JL, Fode-Thomas NC, Fealey RD, Eisenach JH, Goerss SJ (2011) Endoscopic transthoracic limited sympathotomy for palmar-plantar hyperhidrosis: outcomes and complications during a 10-year period. Mayo Clin Proc 86(8):721–729

    Article  PubMed Central  PubMed  Google Scholar 

  2. Baumann L, Slezinger A, Halem M, Vujevich J, Mallin K, Charles C, Martin LK, Black L, Bryde J (2005) Double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis. Dermatol Surg 31(3):263–270

    Article  CAS  PubMed  Google Scholar 

  3. Baumann L, Slezinger A, Halem M, Vujevich J, Martin LK, Black L, Bryde J (2005) Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis. Int J Dermatol 44(5):418–424

    Article  CAS  PubMed  Google Scholar 

  4. Baumann LS, Halem ML (2003) Systemic adverse effects after botulinum toxin type B (myobloc) injections for the treatment of palmar hyperhidrosis. Arch Dermatol 139(2):226–227

    Article  PubMed  Google Scholar 

  5. Baumann LS, Halem ML (2004) Botulinum toxin-B and the management of hyperhidrosis. Clin Dermatol 22(1):60–65

    Article  PubMed  Google Scholar 

  6. Berweck S, Schroeder AS, Lee SH, Bigalke H, Heinen F (2007) Secondary non-response due to antibodies formation in a child after three injections of botulinum toxin B into salivary glands. Dev Med Child Neurol 49(1):62–64

    Google Scholar 

  7. Bhidayasiri R, Truong DD (2008) Evidence for effectiveness of botulinum toxin for hyperhidrosis. J Neural Transm 115(4):641–645

    Article  CAS  PubMed  Google Scholar 

  8. Campanati A, Bernardini ML, Gesuita R, Offidani A (2007) Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study. Eur J Dermatol 17(1):52–54

    CAS  PubMed  Google Scholar 

  9. Campanati A, Lagalla G, Penna L, Gesuita R, Offidani A (2004) Local neural block at the wrist for treatment of palmar hyperhidrosis with botulinum toxin: technical improvements. J Am Acad Dermatol 51(3):345–348

    Article  PubMed  Google Scholar 

  10. Chia HY, Tan AS, Chong WS, Tey HL (2012) Efficacy of iontophoresis with glycopyrronium bromide for treatment of primary palmar hyperhidrosis. J Eur Acad Dermatol Venereol 26(9):1167–1170

    Article  CAS  PubMed  Google Scholar 

  11. Dressler D, Adib Saberi F, Benecke R (2002) Botulinum toxin type B for treatment of axillar hyperhidrosis. J Neurol 249(12):1729–1732

    Article  CAS  PubMed  Google Scholar 

  12. Dressler D, Benecke R (2003) Autonomic side effects of botulinum toxin type B treatment of cervical dystonia and hyperhidrosis. Eur Neurol 49(1):34–38

    Article  CAS  PubMed  Google Scholar 

  13. Fiorelli A, D’Aponte A, Canonico R, Palladino A, Vicidomini G, Limongelli F, Santini M (2012) T2–T3 sympathectomy versus sympathicotomy for essential palmar hyperhidrosis: comparison of effects on cardio-respiratory function. Eur J Cardiothorac Surg 42(3):454–461

    Article  PubMed  Google Scholar 

  14. Glass GE, Hussain M, Fleming AN, Powell BW (2009) Atrophy of the intrinsic musculature of the hands associated with the use of botulinum toxin-A injections for hyperhidrosis: a case report and review of the literature. J Plast Reconstr Aesthet Surg 62(8):e274–e276

    Article  CAS  PubMed  Google Scholar 

  15. Gregoriou S, Rigopoulos D, Makris M, Liakou A, Agiosofitou E, Stefanaki C, Kontochristopoulos G (2010) Effects of botulinum toxin-a therapy for palmar hyperhidrosis in plantar sweat production. Dermatol Surg 36(4):496–498

    Article  CAS  PubMed  Google Scholar 

  16. Hecht MJ, Birklein F, Winterholler M (2004) Successful treatment of axillary hyperhidrosis with very low doses of botulinum toxin B: a pilot study. Arch Dermatol Res 295(8–9):318–319

    Article  PubMed  Google Scholar 

  17. Hoorens I, Ongenae K (2012) Primary focal hyperhidrosis: current treatment options and a step-by-step approach. J Eur Acad Dermatol Venereol 26(1):1–8

    Article  CAS  PubMed  Google Scholar 

  18. Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, Ahn S, Stolman LP, Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis (2004) Recognition, diagnosis, and treatment of primary focal hyperhydrosis. J Am Acad Dermatol 51:274–286

    Article  PubMed  Google Scholar 

  19. Intiso D, Basciani M (2012) Botulinum toxin use in neuro-rehabilitation to treat obstetrical plexus palsy and sialorrhea following neurological diseases: a review. NeuroRehabilitation 31(2):117–129

    PubMed  Google Scholar 

  20. Iwase S, Ikeda T, Kitazawa H, Hakusui S, Sugenoya J, Mano T (1997) Altered response in cutaneous sympathetic outflow to mental and thermal stimuli in primary palmoplantar hyperhidrosis. J Auton Nerv Syst 64:65–73

    Article  CAS  PubMed  Google Scholar 

  21. Karlqvist M, Rosell K, Rystedt A, Hymnelius K, Swartling C (2013) Botulinum toxin B in the treatment of craniofacial hyperhidrosis J Eur Acad Dermatol Venereol. doi:10.1111/jdv.12278 [Epub ahead of print]

  22. Klein AW (2004) Complications with the use of botulinum toxin. Dermatol Clin 22:197–205

    Article  CAS  PubMed  Google Scholar 

  23. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S (2002) Efficacy and safety of botulinum toxin type A in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study. Dermatol Surg 28:822–827

    Article  PubMed  Google Scholar 

  24. Müller C, Berensmeier A, Hamm H, Dirschka T, Reich K, Fischer T, Rzany B (2013) Efficacy and safety of methantheline bromide (Vagantin) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial. J Eur Acad Dermatol Venereol 27(10):1278–1284

    PubMed  Google Scholar 

  25. Nelson L, Bachoo P, Holmes J (2005) Botulinum toxin type B: a new therapy for axillary hyperhidrosis. Br J Plast Surg 58(2):228–232

    Article  CAS  PubMed  Google Scholar 

  26. Pena MA, Alam M, Yoo SS (2007) Complications with the use of botulinum toxin type A for cosmetic applications and hyperhidrosis. Semin Cutan Med Surg 26(1):29–33

    Article  CAS  PubMed  Google Scholar 

  27. Racette BA, Lopate G, Good L, Sagitto S, Perlmutter JS (2002) Ptosis as a remote effect of therapeutic botulinum toxin B injection. Neurology 59:1445–1447

    Article  CAS  PubMed  Google Scholar 

  28. Rosell K, Hymnelius K, Swartling C (2013) Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Acta Derm Venereol 93(3):335–339

    Article  PubMed  Google Scholar 

  29. Rystedt A, Karlqvist M, Bertilsson M, Naver H, Swartling C (2013) Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study. Acta Derm Venereol 93(6):674–678

    Article  CAS  PubMed  Google Scholar 

  30. Rystedt A, Swartling C, Färnstrand C, Naver H (2008) Equipotent concentrations of Botox and Dysport in the treatment of palmar hyperhidrosis. Acta Derm Venereol 88(5):458–461

    Article  CAS  PubMed  Google Scholar 

  31. Saadia D, Voustianouk A, Wang AK, Kaufmann H (2001) Botulinum toxin type A in primary palmar hyperhidrosis. Randomized, single-blind, two-dose study. Neurology 57:2095–2099

    Article  CAS  PubMed  Google Scholar 

  32. Schnider P, Binder M, Auff E, Kittler H, Berger T, Wolff K (1997) Double blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms. Br J Dermatol 136:548–552

    Google Scholar 

  33. Simonetta Moreau M, Cauhepe C, Magues JP, Senard JM (2003) A double-blind, randomized, comparative study of Dysport vs. Botox in primary palmar hyperhidrosis. Br J Dermatol 149(5):1041–1045

    Article  CAS  PubMed  Google Scholar 

  34. Solish N, Bertucci V, Dansereau A, Hong HC, Lynde C, Lupin M, Smith KC, Storwick G, Canadian Hyperhidrosis Advisory Committee (2007) A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee. Dermatol Surg 33(8):908–923

    Article  CAS  PubMed  Google Scholar 

  35. Swartling C, Färnstrand C, Abt G, Stålberg E, Naver H (2001) Side-effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: a neurophysiological study. Eur J Neurol 8:451–456

    Article  CAS  PubMed  Google Scholar 

  36. Tintner R, Gross R, Winzer UF, Smalky KA, Jankovic J (2005) Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial. Neurology 65:765–767

    Article  CAS  PubMed  Google Scholar 

  37. Wolosker N, de Campos JR, Kauffman P, Puech-Leão P (2012) A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg 55(6):1696–1700

    Article  PubMed  Google Scholar 

  38. Yamashita N, Shimizu H, Kawada M, Yanagishita T, Watanabe D, Tamada Y, Matsumoto Y (2008) Local injection of botulinum toxin A for palmar hyperhidrosis: usefulness and efficacy in relation to severity. J Dermatol 35(6):325–329

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

No competing financial and conflict of interests exist.

Author information

Authors and Affiliations

  1. Unit of Neuro-rehabilitation, Hospital Scientific Institute “Casa Sollievo Della Sofferenza”, Viale dei Cappuccini, 71013, San Giovanni Rotondo (FG), Italy

    Mario Basciani, Filomena Di Rienzo & Domenico Intiso

  2. Unit of Dermatology, Hospital SS. Giovanni e Paolo, Venice, Italy

    Malvina Zanchi

  3. Unit of Neurology, Hospital SS. Giovanni e Paolo, Venice, Italy

    Massimo Bizzarrini

  4. Unit of Biostatistics, Hospital Scientific Institute “Casa Sollievo Della Sofferenza”, Viale dei Cappuccini, 71013, San Giovanni Rotondo (FG), Italy

    Massimiliano Copetti

Authors
  1. Mario Basciani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Filomena Di Rienzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Massimo Bizzarrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Malvina Zanchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Massimiliano Copetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Domenico Intiso
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Intiso.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basciani, M., Di Rienzo, F., Bizzarrini, M. et al. Efficacy of botulinum toxin type B for the treatment of primary palmar hyperhidrosis: a prospective, open, single-blind, multi-centre study. Arch Dermatol Res 306, 497–503 (2014). https://doi.org/10.1007/s00403-014-1449-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-014-1449-7

Keywords

Search

Navigation